DC Chemicals

All products / DC9580

Anagrelide (hydrochloride)
CAT. NO. DC9580

Anagrelide (hydrochloride)

Pack sizes and prices

Pack sizePrice
100 mg$200 USDRequest a quote / confirm availability →
250 mg$400 USDRequest a quote / confirm availability →
1 g$800 USDRequest a quote / confirm availability →

Confirm stock, lead time, shipping and final quotation with our team.

Product overview

Anagrelide Hydrochloride(BL4162A) is a drug used for the treatment of essential thrombocytosis. Anagrelide hydrochloride is an oral imidazoquinazoline agent that has been shown to reduce elevated platelet counts and the risk of thrombosis in patients with thrombocythaemia in various myeloproliferative disorders (MPD). It is currently approved by the FDA as oral treatment for essential thrombocythaemia (ET) and thrombocythaemia associated with polycythaemia vera (PV). Anagrelide is known to inhibit platelet cyclic adenosine monophosphate (cAMP) phosphodiesterase at concentrations that exceed those achieved at doses used to treat ET. Anagrelide is extensively metabolised in the liver and its metabolites are primarily excreted in the urine. Anagrelide is an established platelet-reducing drug. Studies have also investigated the effects of anagrelide on platelets, indicating that platelet function is as important as platelet counts in ET.

For research use only. Results depend on experimental conditions and do not constitute a performance guarantee.

Identity and specifications

Catalog numberDC9580
Product nameAnagrelide (hydrochloride)
CAS58579-51-4
Molecular formulaC10H8Cl3N3O
Molecular weight292.549
Purity>98%
SMILESCl.O=C1CN2Cc3c(ccc(Cl)c3Cl)NC2=N1

Source-listed specifications; the batch COA applies.

Source and product documents

The supplier source is linked below. Contact us for COA, SDS and batch-specific documents.

DC Chemicals — Anagrelide (hydrochloride) (DC9580)

Related research products

Browse newly added products